Document Detail


Why use placebos in clinical trials? A narrative review of the methodological literature.
MedLine Citation:
PMID:  10729687     Owner:  NLM     Status:  MEDLINE    
Abstract/OtherAbstract:
Researchers have a number of different options for their choice of control or comparison intervention in randomized trials. We surveyed the methodological literature looking for reasons why a researcher might choose to administer a placebo (i.e., a mimic intervention) to control subjects. Two implicit assumptions were that the issue of placebo is pertinent only to drug trials and that the nonplacebo effect of a treatment is the "real" or "true" effect. Explicit reasons given in the literature for the use of placebos were facilitating blinding and controlling for the placebo effect. The importance of the latter was often inadequately argued. Reasons to avoid placebos in controlled trials, other than ethics and feasibility, are that placebos do not inform real decisions, and may interfere with accurate estimation of effect size and with nonspecific aspects of treatment. Placebo-controlled trials have high internal validity but may be difficult to apply to clinical practice; the situation is reversed for trials without placebo control.
Authors:
A J Vickers; A J de Craen
Related Documents :
21344827 - Plaque and gingivitis reduction efficacy of an advanced pulsonic toothbrush: a 4-week r...
3555627 - A controlled trial of methylene blue in severe depressive illness.
20098527 - Safety and tolerability of adjunctive aripiprazole in major depressive disorder: a pool...
11342997 - A new study demonstrates the efficacy of naftidrofuryl in the treatment of intermittent...
3157727 - Drug response as a predictor of transmission of non-bipolar major depression within fam...
3553247 - Superpotent topical steroid treatment of psoriasis vulgaris--clinical efficacy and adre...
Publication Detail:
Type:  Journal Article; Review    
Journal Detail:
Title:  Journal of clinical epidemiology     Volume:  53     ISSN:  0895-4356     ISO Abbreviation:  J Clin Epidemiol     Publication Date:  2000 Feb 
Date Detail:
Created Date:  2000-04-07     Completed Date:  2000-04-07     Revised Date:  2007-11-15    
Medline Journal Info:
Nlm Unique ID:  8801383     Medline TA:  J Clin Epidemiol     Country:  ENGLAND    
Other Details:
Languages:  eng     Pagination:  157-61     Citation Subset:  IM    
Affiliation:
Integrative Medicine Service and Biostatistics Service, Memorial Sloan-Kettering Cancer Center, 1275 York Avenue, New York, NY 11215, USA. vickersa@mskcc.org
Export Citation:
APA/MLA Format     Download EndNote     Download BibTex
MeSH Terms
Descriptor/Qualifier:
Double-Blind Method
Epidemiologic Research Design
Humans
Placebos / therapeutic use*
Randomized Controlled Trials as Topic / methods*,  standards
Chemical
Reg. No./Substance:
0/Placebos

From MEDLINE®/PubMed®, a database of the U.S. National Library of Medicine


Previous Document:  Stillbirth risk with social class and deprivation: no evidence for increasing inequality.
Next Document:  Incorporating patient preferences into randomized trials.